Maleimide conjugation markedly enhances the immunogenicity of both human and murine idiotype-KLH vaccines

This publication has 42 references indexed in Scilit:

• Clinical Benefit Associated With Idiotypic Vaccination in Patients With Follicular Lymphoma
  JNCI Journal of the National Cancer Institute, 2006
• A critical review of analytical ultracentrifugation and field flow fractionation methods for measuring protein aggregation
  The AAPS Journal, 2006
• Pathogen recognition and development of particulate vaccines: Does size matter?
  Methods, 2006
• Phase II Trial of Idiotype Vaccination in Previously Treated Patients With Indolent Non-Hodgkin’s Lymphoma Resulting in Durable Clinical Responses
  Journal of Clinical Oncology, 2006
• Recombinant, tumour-derived idiotype vaccination for indolent B cell non-Hodgkin’s lymphomas: a focus on FavId™
  Expert Opinion on Biological Therapy, 2005
• Clinical Outcome of Lymphoma Patients After Idiotype Vaccination Is Correlated With Humoral Immune Response and Immunoglobulin G Fc Receptor Genotype
  Journal of Clinical Oncology, 2004
• Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients
  Blood, 2002
• (6-Maleimidocaproyl)hydrazone of doxorubicin. A new derivative for the preparation of immunoconjugates of doxorubicin
  Bioconjugate Chemistry, 1993
• Induction of Immune Responses in Patients with B-Cell Lymphoma against the Surface-Immunoglobulin Idiotype Expressed by Their Tumors
  New England Journal of Medicine, 1992
• Conjugation of Glucose Oxidase from Aspergillus niger and Rabbit Antibodies Using N-Hydroxysuccinimide Ester of N-(4-Carboxycyclohexylmethyl)-Maleimide
  European Journal of Biochemistry, 1979